The drug safety review process.
作者信息
Somberg J
出版信息
Am J Ther. 2007 Mar-Apr;14(2):119. doi: 10.1097/MJT.0b013e31804d45f6.
PMID:17414577
Abstract
摘要
相似文献
1
The drug safety review process.药物安全性审查过程。
Am J Ther. 2007 Mar-Apr;14(2):119. doi: 10.1097/MJT.0b013e31804d45f6.
2
Safety in numbers--monitoring risk in approved drugs.人多势众——监测已获批药物的风险
N Engl J Med. 2005 Mar 24;352(12):1173-6. doi: 10.1056/NEJMp058029.
3
Contributing to drug safety.促进药物安全。
Am J Hosp Pharm. 1990 Jun;47(6):1280.
4
Opening Pandora's pillbox: using modern information tools to improve drug safety.打开潘多拉的药盒：利用现代信息工具提高用药安全。
Health Aff (Millwood). 2005 Jul-Aug;24(4):938-48. doi: 10.1377/hlthaff.24.4.938.
5
"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.“黑匣子”101：美国食品药品监督管理局如何评估、沟通和管理药品的益处/风险。
J Allergy Clin Immunol. 2006 Jan;117(1):34-9. doi: 10.1016/j.jaci.2005.10.031.
6
Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.麻烦的处方：常见药物，隐藏危险。数十人处于危险之中。
Consum Rep. 2006 Jan;71(1):34-9.
7
Pharmaceutical postmarket review: fact or fiction?
Food Drug Law J. 2007;62(3):493-500.
8
Controversies in adverse drug reaction reporting.
Am J Hosp Pharm. 1990 Jan;47(1):76-7.
9
Should new drugs be avoided?应该避免使用新药吗？
Child Health Alert. 2002 Jun;20:2.
10
Revised ADR report permits internal review of drug experience.
Pharm Times. 1986 Dec;52(12):48-50.
Zotero 插件